VIVUS Reports Data Supporting the Cardiovascular Safety of Qsymia®
-Retrospective analysis presented at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management- CAMPBELL, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, …